Search Result "Canagliflozin"
Safety of Canagliflozin in Patients with Type 2 Diabetes
Journal: Current Drug Safety
Volume: 9 Issue: 2 Year: 2014 Page: 127-132
Author(s): Nasser Mikhail
Canagliflozin : A New Hope in the Antidiabetic Armamentarium
Journal: Recent Patents on Cardiovascular Drug Discovery
Volume: 8 Issue: 3 Year: 2013 Page: 216-220
Author(s): Vasiliki K. Katsi,Christos A. Michalakeas,Charalambos E. Grassos,Georgia D. Vamvakou,John P. Lekakis,Dimitris Tousoulis,Christodoulos I. Stefanadis,Thomas K. Makris,Ioannis E. Kallikazaros
Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?
Journal: Current Drug Safety
Volume: 13 Issue: 1 Year: 2018 Page: 38-40
Author(s): Piero Vasapollo,Erika Cione,Filippo Luciani,Luca Gallelli
A Systematic Review on Effect of Canagliflozin in Special Population
Journal: Current Diabetes Reviews
Volume: 12 Issue: 3 Year: 2016 Page: 211-222
Author(s): Sanket Patel,Kalpesh Gohel,Bharat Gordhanbhai Patel
Role of Porous Carriers in the Biopharmaceutical Performance of Solid SMEDDS of Canagliflozin
Journal: Recent Patents on Drug Delivery & Formulation
Volume: 12 Issue: 3 Year: 2018 Page: 179-198
Author(s): Dilpreet Singh,Ashok K. Tiwary,Neena Bedi
Invokana (Canagliflozin) as a Dual Inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: Advancement in Alzheimerâs Disease- Diabetes Type 2 Linkage via an Enzoinformatics Study
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 3 Year: 2014 Page: 447-451
Author(s): Syed M.D. Rizvi,Shahnawaz Shakil,Deboshree Biswas,Shazi Shakil,Sibhghatulla Shaikh,Paramdeep Bagga,Mohammad A. Kamal
Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition with Canagliflozin in Type 2 Diabetes Mellitus
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2013 Page: 203-206
Author(s): Sarmad Said,German T. Hernandez
A Review of Sodium Glucose Co-transporter 2 Inhibitors Canagliflozin, Dapagliflozin and Empagliflozin
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2015 Page: 105-112
Author(s): Saad Hussain Syed,Sucheta Gosavi,Waseem Shami,Marco Bustamante,Zul Farah,Muhammad Teleb,Aamer Abbas,Sarmad Said,Debabrata Mukherjee
Effect of Canagliflozin, an SGLT2 Inhibitor, in Comparison with Atorvastatin on Dexamethasone-Induced Hepatic Steatosis in Albino Rats
Journal: Current Drug Therapy
Volume: 15 Issue: 3 Year: 2020 Page: 274-282
Author(s): Eman I. Ahmed,Amany M. Shaaban,Abdel Karim M. Abdel Latif
Polymeric Precipitation Inhibitor Based Supersaturable Self-microemulsifying Drug Delivery System of Canagliflozin: Optimization and Evaluation
Journal: Current Drug Delivery
Volume: 18 Issue: 9 Year: 2021 Page: 1352-1367
Author(s): Dilpreet Singh,Ashok K. Tiwary,Tejwant Singh Kang,Neena Bedi